drugset / Trial / NCT00020189

Flavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

NCT00020189

Treatment

Summary

RATIONALE: Drugs used in chemotherapy work in different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of flavopiridol in treating patients who have recurrent or metastatic head and neck cancer.

Timeline

Start
2000-06
Primary completion
Completion
2004-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Aspirin Small molecule Oral
Subject alvocidib Small molecule Intravenous
Subject clopidogrel bisulfate Unknown Oral